Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2003
05/01/2003WO2003035827A2 Plasticized hydrophilic glasses for improved stabilization of biological agents
05/01/2003WO2003035790A2 Improved method for generating an aerosol
05/01/2003WO2003035701A1 Carrageenan-containing composition with improved gelling properties
05/01/2003WO2003035237A2 Compounds for use as surfactants
05/01/2003WO2003035177A2 Optimal polymer mixtures for gastric retentive tablets
05/01/2003WO2003035114A1 Radiopharmaceutical agent for the treatment of early stage cancer
05/01/2003WO2003035113A1 Magnetic nanodispersion comprising cyclodextrines and method for the production thereof
05/01/2003WO2003035112A1 Enteral nutrient and process for producing the same
05/01/2003WO2003035092A1 Composition containing horse chestnut extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
05/01/2003WO2003035089A1 Preventives/remedies for foot and mouth disease
05/01/2003WO2003035080A2 A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
05/01/2003WO2003035063A1 Novel preparation of selective cyclooxygenase ii inhibitors
05/01/2003WO2003035054A1 Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
05/01/2003WO2003035053A1 Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
05/01/2003WO2003035044A2 Production of starch-gel-based shaped bodies
05/01/2003WO2003035043A2 Pharmaceutical formulation comprising more than 15% tamoxifen
05/01/2003WO2003035042A1 Use of a multi-layer controlled-release tablet comprising ropinirole for the manufacture of medicament for the treatment of fibromyalgia
05/01/2003WO2003035041A1 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
05/01/2003WO2003035040A1 Methods of treatment using a gastric retained gabapentin dosage
05/01/2003WO2003035039A1 Methods of treatment using a gastric retained losartan dosage
05/01/2003WO2003035037A1 Solid pharmaceutical formulation for a piperazine urea derivative
05/01/2003WO2003035036A1 Montelukast granule formulation
05/01/2003WO2003035031A1 Stable composition comprising particles in a frozen aqueous matrix
05/01/2003WO2003035030A1 Kit for the preparation of a pharmaceutical composition
05/01/2003WO2003035029A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/01/2003WO2003035027A1 Chewable tablet containing lysine
05/01/2003WO2003035026A2 Polysaccharide-based network and method for the production thereof
05/01/2003WO2003035021A1 Potentiated topical composition
05/01/2003WO2003035012A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003WO2003035007A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
05/01/2003WO2003035002A2 Management of postoperative pain
05/01/2003WO2003034999A2 Medication and method for remediating existing scars through transdermal topical delivery of calcium channel blockers
05/01/2003WO2003034995A2 Integrin targeting compounds
05/01/2003WO2003034991A2 Taste masking spill-resistant formulation
05/01/2003WO2003034988A2 Injectable compositions for the controlled delivery of pharmacologically active compound
05/01/2003WO2003034983A2 Compositions and a new method for making a water-in-oil emulsion
05/01/2003WO2003034980A2 A novel pharmaceutical compound containing abacavir sulfate and methods of making and using same
05/01/2003WO2003034975A2 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2003034900A2 Sterile, breathable patch for treating wound pain
05/01/2003WO2003026637A3 Dosage form for treatment of diabetes mellitus
05/01/2003WO2003026628A3 Composite dosage forms having an inlaid portion
05/01/2003WO2003017976B1 Synergistic mixed poloxamer systems for the solubilisation of drugs
05/01/2003WO2003009829A3 Antiemetic, anti-motion sustained release drug delivery system
05/01/2003WO2003007912A3 Lyophilized formulation comprising olanzapine
05/01/2003WO2003005989A3 Granulates containing liposoluble substances and a process for the preparation thereof
05/01/2003WO2003002152A3 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins
05/01/2003WO2003000777A3 Multi-arm block copolymers as drug delivery vehicles
05/01/2003WO2002102413A3 Alkali or alkaline earth metal benzoate particles
05/01/2003WO2002100336A3 Tissue-specific endothelial membrane proteins
05/01/2003WO2002098897A3 Modified antibodies to prostate-specific membrane antigen and uses thereof
05/01/2003WO2002096435A3 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
05/01/2003WO2002094215A3 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vimyl acetate as surface stabilizers
05/01/2003WO2002089835A3 Pharmaceutical dosage form of amorphous nelfinavir mesylate
05/01/2003WO2002083151A3 Compositions and methods for treating an arthritic condition
05/01/2003WO2002074806A3 New interferon beta-like molecules
05/01/2003WO2002067897A3 In-situ gel formation of pectins
05/01/2003WO2002067850A9 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging
05/01/2003WO2002060458A3 Compositions and method of tissue superoxygenation
05/01/2003WO2002043739A3 Dermatological formulations containing clindamycin and a zinc-salt
05/01/2003WO2002040056A3 Carrageenan viscoelastics for ocular surgery
05/01/2003WO2002030409A9 Methods for the treatment of a traumatic central nervous system injury
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003WO2002013873A3 P97-active agent conjugates and their methods of use
05/01/2003WO2002005834A3 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
05/01/2003WO2002000244A3 Protein mixtures for wound healing
05/01/2003US20030083733 Sustained release, via stent/catheter, of cytochalasin (or derivative) for inhibiting restenosis/cellular proliferation
05/01/2003US20030083614 For insertion at a vascular site via catheter placement to treat or prevent fibrin-dependent microcirculation disorders; self-expanding; drug-delivery
05/01/2003US20030083610 Compositions and method of tissue superoxygenation
05/01/2003US20030083389 Bifunctional-modified hydrogels
05/01/2003US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
05/01/2003US20030083380 Comprises 2-ketoethanoic acid for cosmetic conditions and dermatologic disorders
05/01/2003US20030083360 Compaction process for manufacture of sodium phenytoin dosage form
05/01/2003US20030083322 For androgenic alopecia or hirsutism; physiologically tolerated film-forming agent and solvent, a plasticizer and compound such as 4-(5-methyl-2,4-dioxo-5-trifluoromethyl)-oxazolidin-3-yl)-2 -(trifluoromethyl)-benzonitrile
05/01/2003US20030083310 Process for producing an iron-dextran compound, iron-dextran compound produced according to said process, pharmaceutical composition for prophylaxis or treatment of iron-deficiency and use of said compound for the preparation of a parenterally administrable pharmaceutical composition
05/01/2003US20030083308 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses
05/01/2003US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides
05/01/2003US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues
05/01/2003US20030083232 And fatty acid component and bile salt component; treating insulin deficiency; oral administration
05/01/2003US20030082814 Secretion of T cell receptor fragments from recombinant escherichia coli cells
05/01/2003US20030082786 PEG-modified uricase
05/01/2003US20030082784 Novel peptide having osteogenetic activity and osteogenetic accelerator containing the same
05/01/2003US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082243 Generation of therapeutic microfoam
05/01/2003US20030082240 Porous sphere of calcium carbonate
05/01/2003US20030082239 Antifungal compositions with improved bioavailability
05/01/2003US20030082238 Matrices for drug delivery and methods for making and using the same
05/01/2003US20030082237 Binding to block polymer, polyelectrolytes; drug delivery, magnetism, optics, electronics
05/01/2003US20030082235 Novel reverse thermo-sensitive block copolymers
05/01/2003US20030082234 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
05/01/2003US20030082232 Adjust particle size; induce immunology response; vaccines
05/01/2003US20030082231 Mixture of cellulose ether and chlorophyll chelate compound
05/01/2003US20030082230 Chronotherapeutic dosage forms and methods of treatment using chronotherapy
05/01/2003US20030082229 Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use
05/01/2003US20030082227 Drug delivery; multilayer reservoir
05/01/2003US20030082226 Non-steroidal antiinflammatory drug formulations for topical application to the skin
05/01/2003US20030082225 Sterile, breathable patch for treating wound pain
05/01/2003US20030082224 Antitumor, anticancer agents
05/01/2003US20030082223 Mixture contains flow control agent and thickener
1 ... 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 ... 1712